A psychoneuroendocrine perspective on the management of fibromyalgia syndrome

Journal of Musculoskeletal Pain

Volumn 17, Issue 2, 2009, Pages 178-188

  Geenen, Rinie ^a,b   Jacobs, Johannes W G ^a   Bijlsma, Johannes W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Autonomic nervous system; Biopsychosocial model; Fibromyalgia syndrome; Hypothalamic pituitary adrenal axis; Stress

Indexed keywords

ADRENALIN; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BEVACIZUMAB; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FOLLITROPIN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PARACETAMOL; PREDNISONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN; SUBSTANCE P; THYROTROPIN; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENAL CORTEX; ADRENERGIC SYSTEM; ANALGESIA; ANGER; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BRAIN NERVE CELL; CAUSAL ATTRIBUTION; COGNITIVE THERAPY; DISTRESS SYNDROME; DRUG TREATMENT FAILURE; ENDOCRINE DISEASE; EXERCISE; FIBROMYALGIA; FITNESS; GONAD; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION; LIVER; LOCUS CERULEUS; MENTAL HEALTH; MENTAL STRESS; NERVE CELL; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NEUROPSYCHOLOGY; NORADRENALIN RELEASE; PAIN; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RECEPTOR UPREGULATION; REVIEW; SLEEP DISORDER; SPINAL CORD DORSAL HORN; STRESS MANAGEMENT; THYROID GLAND; VASOCONSTRICTION;

EID: 61649106649     PISSN: 10582452     EISSN: 15407012     Source Type: Journal    
DOI: 10.1080/10582450902816521     Document Type: Review

References (84)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia - report of the multicenter criteria committee. Arthritis Rheum 33(2): 160-172,1990.
2. Henriksson KG, Sorensen J: The promise of N- methyl-D-aspartate receptor antagonists in fibromyalgia. Rheum Dis Clin North Am 28: 343-351, 2002.
3. Sorensen J, Bengtsson A, Backman E, Henriks- son KG, Bengtsson M: Pain analysis in patients with fibromyalgia - effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 24: 360-365, 1995.
4. Mense S: Neurobiological concepts of fibromyalgia - the possible role of descending spinal tracts. Scand J Rheumatol 29: 24-29, 2000.
5. Russell IJ: Advances in fibromyalgia: Possible role for central neurochemicals. Am J Med Sci 315: 377-384,1998.
6. Henriksson KG: The fibromyalgia syndrome [FMS]. Translating science into clinical practice. J Musculoskelet Pain: 2009, in press.
7. Melzack R: From the gate to the neuromatrix. Pain Suppl. 6: S121-S126,1999.
8. Bennett RM, Clark SC, Walczyk J: A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 104: 227-231,1998.
9. Van Houdenhove B, Luyten P, Egle UT: Stress as a key-concept in chronic widespread pain and fatigue disorders. J Musculoskelet Pain: 2009, in press.
10. Geenen R, Jacobs JWG, Bijlsma JWJ: Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 28: 389-104, 2002.
11. Griep EN, Boersma JW, de Kloet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20: 469-474,1993.
12. Griep EN, Boersma JW, Lentjes EGWM, Prins APA, de Kloet ER: Difference in hypothalamic pituitary-adrenal response pattern in fibromyalgia and chronic fatigue syndrome. Fibromyalgia syndrome neuroendocrine perspectives with clinical implications. Edited by EN Griep. PhD Thesis. University of Leiden, Leiden, 2001, pp. 131-151.
13. Crofford LJ, Engleberg NC, Demi track MA: Neurohormonal perturbations in fibromyalgia. Baillieres Clin Rheumatol 10: 365-378,1996.
14. Neeck G, Riedel W: Hormonal pertubations in fibromyalgia syndrome. Ann N Y Acad Sci 876: 325- 338,1999.
15. Riedel W, Layka H, Neeck G: Secretory pattern of GH, TSH, thyroid hormones, ACTH, Cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic- releasing hormones. Z Rheumatol 57: 81-87,1998.
16. Ferraccioli G, Cavalieri F, Salaffi F, Fontana S, Scita F, Nolli M, et al.: Neuroendocrinologic findings in primary fibromyalgia (soft-tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid-arthritis, low-back-pain). J Rheumatol 17: 869-873,1990.
17. Griep EN, Boersma JW, Lentjes E, Prins APA, van der Korst JK, de Kloet ER: Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25:1374- 1381,1998.
18. Hudson JI, Pliner LF, Hudson MS, Goldenberg DL, Melby JC: The dexamethasone suppression test in fibrositis. Biol Psychiatry 19: 1489-1493,1984.
19. Adler GK, Geenen R: Hypothalamic-pituitary- adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin North Am 31: 187-202, 2005.
20. Thieme K, Rose U, Pinkpank T, Spies C, Turk DC, Flor H: Psychophysiological responses in patients with fibromyalgia syndrome. J Psychosom Res 61: 671-679, 2006.
21. Vaeroy H, Qiao ZG, Morkrid L, Forre O: Altered sympathetic nervous-system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 16: 1460-1465,1989.
22. Van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, Van Neerbos BR: Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS) - is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 21: 35-37, 1992.
23. Cook DB, Nagelkirk PR, Poluri A, Mores J, Natelson BH: The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome. Arthritis Rheum 54: 3351-3362, 2006.
24. Martinez-Lavin M, Hermosillo AG, Mendoza C, Ortiz R, Cajigas JC, Pineda C, et al.: Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 24: 714-718,1997.
25. Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbie F, et al.: Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 32:1787-1793, 2005.
26. Bou-Holaigah I, Calkins H, Flynn JA, Tunin C, Chang HC, Kan JS, et al.: Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 15: 239-246, 1997.
27. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary- adrenal axis to interleukin-6-a pilot study in fibromyalgia. Arthritis Rheum 43: 872-880, 2000.
28. Chrousos GP: Neuroendocrine alterations associated with altered sleep, mood, and pain perception. J Musculoskelet Pain 6: 51-55, 1998.
29. Meeus M, Nijs J: Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26: 465-173, 2007.
30. Khasabov SG, Rogers SD, Ghilardi JR, Peters CM, Mantyh PW, Simone DA: Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 22: 9086- 9098,2002.
31. Chowdrey HS, Larsen PJ, Harbuz MS, Lightman SL, Jessop DS: Endogenous substance P inhibits the depression of corticotrophin-releasing hormone during a chronic inflammatory stress. Life Sci 57: 2021-2029, 1995.
32. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP: The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 40: 1928-1939, 1997.
33. Kizildere S, Gluck T, Zietz B, Scholmerich J, Straub RH: During a corticotrophin-releasing hormone test in healthy subjects, administration of a beta adrenergic antagonist induced secretion of Cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH. Eur J Endocrinol 148: 45-53, 2003.
34. Lariviere WR, Melzack R: The role of corticotrophin-releasing factor in pain and analgesia. Pain 84: 1-12, 2000.
35. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising M, et al.: Effects of the high-affinity corticotrophin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated. J Psychiatr Res 34: 171-181, 2000.
36. Sternberg EM: Hypoimmune fatigue syndromes - diseases of the stress response. J Rheumatol 20:418- 421,1993.
37. Dickens C, McGowan L, Dale S: Impact of depression on experimental pain perception: A systematic review of the literature with meta-analysis. Psychosom Med 65: 369-375, 2003.
38. Wood PB, Patterson JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL: Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J Pain 8: 51-58, 2007.
39. Holman AJ, Myers RR: A randomized, double blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52: 2495-2505, 2005.
40. Van Houdenhove B, Neerinckx E, Lysens R, Vertommen H, Van Houdenhove L, Onghena P, et al.: Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care - a controlled study on prevalence and characteristics. Psychosomatics 42: 21-28, 2001.
41. Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 59: 572-577,1997.
42. Weissbecker I, Floyd A, Dedert E, Salmon R, Sephton S: Childhood trauma and diurnal Cortisol disruption in fibromyalgia syndrome. Psychoneuroen- docrinology 31: 312-324, 2006.
43. White KP, Nielson WR, Harth M, Ostbye T, Speechley M: Chronic widespread musculoskeletal pain with or without fibromyalgia: Psychological distress in a representative community adult sample. J Rheumatol 29: 588-594, 2002.
44. Davis SN, Mann S, Galassetti P, Neill RA, Tate D, Ertl AC, et al.: Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49: 1897-1903,2000.
45. Benschop RJ, Brosschot JF, Godaert GLR, Desmet MBM, Geenen R, OlffM, et al.: Chronic stress affects immunological but not cardiovascular responsiveness to acute psychological stress in humans. Am J Physiol 266: R75-R80,1994.
46. Geenen R: The pain is all in the brain. NFA's Fibromyalgia Online Newsletter 5(9): 2005.
47. Burns JW, Kubilus A, Bruehl S: Emotion induction moderates effects of anger management style on acute pain sensitivity. Pain 106: 109-118, 2003.
48. Bruehl S, Chung OY, Burns JW: Anger expression and pain: An overview of findings and possible mechanisms. J Behav Med 29: 593-606, 2006.
49. Pertovaara A: Noradrenergic pain modulation. Prog Neurobiol 80: 53-83, 2006.
50. Martinez-Lavin M, Vidal M, Barbosa RE, Pineda C, Casanova JM, Nava A: Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study. BMC Musculoskelet Disord 2: 2, 2002.
51. Ax AF: The physiological differentiation between fear and anger in humans. Psychosom Med 15:433-442, 1953.
52. Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK: Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86: 1034- 1039, 2001.
53. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low-Levels of somatomedin C in patients with the fibromyalgia syndrome - a possible link between sleep and muscle pain. Arthritis Rheum 35:1113-1116, 1992.
54. Martinez-Lavin M, Hermosillo AG, Rosas M, Soto ME: Circadian studies of autonomic nervous balance in patients with fibromyalgia - a heart rate variability analysis. Arthritis Rheum 41: 1966-1971, 1998.
55. Seligman MEP: What you can change and what you can't. Knopf, New York, 1994.
56. Staud R, Patel R, Koo E, Robinson ME, Price DD: Opposite effects of isometric exercise on central pain mechanisms in fibromyalgia (FM) patients compared to normal controls (NC). Arthritis Rheum 52: S79-S79, 2005.
57. Vlaeyen JWS, Marley S: Cognitive and behavioral factors in fibromyalgia: Mood, goals and stoprules. J Musculoskelet Pain 2009, in press.
58. Vlaeyen JWS, Kolesnijders AMJ, Boeren RGB, Vaneek H: Fear of movement (Re)injury in chronic low- back-pain and its relation to behavioral performance. Pain 62: 363-372,1995.
59. Dishman RK, Jackson EM, Nakamura Y: Influence of fitness and gender on blood pressure responses during active or passive stress. Psychophysiology 39: 568-576, 2002.
60. Ueno LM, Moritani T: Effects of long-term exercise training on cardiac autonomic nervous activities and baroreflex sensitivity. Eur J Appl Physiol 89: 109-114, 2003.
61. Forcier K, Stroud LR, Papandonatos GD: Links between physical fitness and cardiovascular reactiv ity and recovery to psychological stressors: A metaanalysis. Health Psychol 25: 723-739,2006.
62. Jackson EM, Dishman RK: Cardiorespiratory fitness and laboratory stress: A meta-regression analysis. Psychophysiology 43: 57-72, 2006.
63. Geenen R, Jacobs JWG: Fibromyalgia: Diagnosis, pathogenesis, and treatment. Curr Opin Anaesthesiol 14: 533-539, 2001.
64. Goldenberg DL, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA 292: 2388- 2395, 2004.
65. Yunus MB, Masi AT, Aldag JC: Short-term effects of Ibuprofen in primary fibromyalgia syndrome - a double-blind, placebo controlled trial. J Rheumatol 16: 527-532,1989.
66. Biasi G, Manca S, Manganelli S, Marcolongo R: Tramadol in the fibromyalgia syndrome: A controlled clinical trial versus placebo. Int J Clin Pharmacol Res 18: 13-19, 1998.
67. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL: Treatment of fibromyalgia with antidepressants - a meta-analysis. J Gen Intern Med 15: 659-666,2000.
68. Arnold LM, Keck PE, Welge JA: Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41: 104-113, 2000.
69. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, et al.: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia - a randomized, double-blind clinical-trial. Arthritis Rheum 37: 32-40,1994.
70. Arnold LM: Biology and therapy of fibromyalgia - new therapies in fibromyalgia. Arthritis Res Ther 8(4): 212, 2006.
71. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, Mcintosh MJ, et al.: A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 21: 180-191,1999.
72. Mannerkorpi K: Exercise in fibromyalgia. Curr Opin Rheumatol 17: 190-194,2005.
73. Sim J, Adams N: Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain 18: 324-336, 2002.
74. Goldsmith RL, Bloomfield DM, Rosenwinkel ET: Exercise and autonomic function. Coron Artery Dis 11: 129-135, 2000.
75. Iellamo F, Legramante JM, Pigozzi F, Spataro A, Norbiato G, Lucini D, et al.: Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athletes. Circulation 105: 2719-2724, 2002.
76. Salmon P: Effects of physical exercise on anxiety, depression, and sensitivity to stress: A unifying theory. Clin Psychol Rev 21: 33-61, 2001.
77. Stathopoulou G, Powers MB, Berry AC, Smits JAJ, Otto MW: Exercise interventions for mental health: A quantitative and qualitative review. Clin Psychol Sci Pract 13: 179-193, 2006.
78. Nishith P, Duntley SP, Domitrovich PP, Uhles ML, Cook BJ, Stein PK: Effect of cognitive behavioral therapy on heart rate variability during REM sleep in female rape victims with PTSD. J Trauma Stress 16: 247-250, 2003.
79. Sakakibara M, Takeuchi S, Hayano J: Effect of relaxation training on cardiac parasympathetic tone. Psychophysiology 31: 223-228, 1994.
80. Mishima N, Kubota S, Nagata S: Psychophysiological correlates of relaxation induced by standard autogenic training. Psychother Psychosom 68: 207-213, 1999.
81. Lucini D, Riva S, Pizzinelli P, Pagani M: Stress management at the worksite-reversal of symptoms profile and cardiovascular dysregulation. Hypertension 49: 291-297, 2007.
82. Bennett R, Nelson D: Cognitive behavioral therapy for fibromyalgia. Nat Clin Pract Rheumatal 2: 416- 424, 2006.
83. Van Koulil S, Effting M, Kraaimaat FW, Van Lankveld W, Van Helmond T, Cats H, et al.: Cognitive behavioural therapies and exercise programmes for patients with fibromyalgia: State of the art and future directions. Ann Rheum Dis, 66, 571-581, 2007.
84. Turk DC, Okifuji A: Pain in patients with fibromyalgia syndrome. Curr Rheumatol Rep 2:109-115, 2000.